<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Zhang Z</submitter><funding>NIA NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pubmed_abstract>Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are common in multiple types of human cancer, leading to the accumulation of D-2-hydroxyglutarate (D2HG) and the promotion of tumorigenesis&lt;sup>1&lt;/sup>. Here we discovered a novel &lt;i>O&lt;/i>-2-hydroxyglutarylation by D2HG using chemical proteomics and further revealed distinct chiral preferences for D/L2HG modifications. Notably, we identified two kinases, MRCKA and SLK, modified by D2HG and L2HG respectively, and detected reduced phosphorylation of their substrates, suggesting an inhibitory effect of D/L 2HG modifications on the kinases' activity.</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2025.01.24.634716</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11838245</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Discovery of Chirally-dependent Protein &lt;i>O&lt;/i>-2-Hydroxyglutarylation by D2HG and L2HG.</pubmed_title><pmcid>PMC11838245</pmcid><funding_grant_id>R01 AG064250</funding_grant_id><funding_grant_id>P30 CA023168</funding_grant_id><funding_grant_id>R01 CA069202</funding_grant_id><funding_grant_id>R35 GM138002</funding_grant_id><pubmed_authors>Wu MJ</pubmed_authors><pubmed_authors>Xue F</pubmed_authors><pubmed_authors>Bardeesy N</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Luo Z</pubmed_authors><pubmed_authors>Zhang ZY</pubmed_authors><pubmed_authors>Liu YK</pubmed_authors><pubmed_authors>Qu Z</pubmed_authors><pubmed_authors>Tao WA</pubmed_authors><pubmed_authors>Parkinson EI</pubmed_authors><pubmed_authors>Evans CN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Discovery of Chirally-dependent Protein &lt;i>O&lt;/i>-2-Hydroxyglutarylation by D2HG and L2HG.</name><description>Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are common in multiple types of human cancer, leading to the accumulation of D-2-hydroxyglutarate (D2HG) and the promotion of tumorigenesis&lt;sup>1&lt;/sup>. Here we discovered a novel &lt;i>O&lt;/i>-2-hydroxyglutarylation by D2HG using chemical proteomics and further revealed distinct chiral preferences for D/L2HG modifications. Notably, we identified two kinases, MRCKA and SLK, modified by D2HG and L2HG respectively, and detected reduced phosphorylation of their substrates, suggesting an inhibitory effect of D/L 2HG modifications on the kinases' activity.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-18T13:52:53.446Z</modification><creation>2025-04-06T23:41:31.536Z</creation></dates><accession>S-EPMC11838245</accession><cross_references><pubmed>39975355</pubmed><doi>10.1101/2025.01.24.634716</doi></cross_references></HashMap>